Article: Rodent Modeling of Alzheimer's Disease in Down Syndrome:
2022 Volume 16, Page(s) 909669
Abstract: There are an estimated 6 million people with Down syndrome (DS) worldwide. In developed countries, the vast majority of these individuals will develop Alzheimer's disease neuropathology characterized by the accumulation of amyloid-β (Aβ) plaques and tau ... ...
Abstract | There are an estimated 6 million people with Down syndrome (DS) worldwide. In developed countries, the vast majority of these individuals will develop Alzheimer's disease neuropathology characterized by the accumulation of amyloid-β (Aβ) plaques and tau neurofibrillary tangles within the brain, which leads to the early onset of dementia (AD-DS) and reduced life-expectancy. The mean age of onset of clinical dementia is ~55 years and by the age of 80, approaching 100% of individuals with DS will have a dementia diagnosis. DS is caused by trisomy of chromosome 21 (Hsa21) thus an additional copy of a gene(s) on the chromosome must cause the development of AD neuropathology and dementia. Indeed, triplication of the gene |
---|---|
Language | English |
Publishing date | 2022-06-07 |
Publishing country | Switzerland |
Document type | Journal Article ; Review |
ZDB-ID | 2411902-7 |
ISSN | 1662-453X ; 1662-4548 |
ISSN (online) | 1662-453X |
ISSN | 1662-4548 |
DOI | 10.3389/fnins.2022.909669 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.